Expert Ratings for Axsome Therapeutics
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 11 analysts have published their opinion on Axsome Therapeutics (NASDAQ:AXSM) stock. The company has an average price target of $115.45 with a high of $200.00 and a low of $87.00. The average price target has increased by 6.11% over the past month.
July 17, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Axsome Therapeutics has received positive ratings from analysts with an average price target of $115.45, indicating potential upside.
Analysts' ratings are a significant factor that investors consider when making investment decisions. The positive ratings and increased price target for Axsome Therapeutics suggest that analysts believe the company's stock has potential for growth, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100